Delivery Order SPE2DE24D0013-SPE2D625F0GAL
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,410.20 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a task order under Cepheid's broader contract vehicle with the federal government. The contract requires performance at Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- The Defense Logistics Agency awarded a $19.25K delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, under a firm fixed-price contract with an ultimate completion date of August 6, 2025. This non-set-aside delivery order (Contract No. 4568946540, designated XPRSARS-COV2-10) procures molecular diagnostic solutions, consistent with Cepheid's core business of providing advanced diagnostic systems and test kits for infectious diseases, including...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (under the Medical Supply Chain operations) to Cepheid Inc., carries a firm fixed-price ceiling value of $27,235.80 with an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and is performed in Sunnyvale, California, where Cepheid maintains its headquarters. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, will deliver products or services under this...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0GALDelivery Order
The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing supply of molecular diagnostic solutions to the federal government's medical supply chain operations. The contractor is well-established in the federal procurement landscape, holding two significant Indefinite Delivery Vehicles with the Veterans Integrated Service Network totaling over $35 million in potential value. Cepheid's core offerings include GeneXpert diagnostic systems, reagents, and test kits designed to detect infectious diseases such as COVID-19, influenza, RSV, and other conditions requiring rapid molecular testing. The relatively modest contract value of this delivery order suggests it represents a specific, focused procurement for diagnostic supplies or services needed to support federal healthcare operations and military medical readiness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.3k | 8/5/25 |